Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS vs NARAYANA HRUDAYALAYA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KRSNAA DIAGNOSTICS NARAYANA HRUDAYALAYA KRSNAA DIAGNOSTICS/
NARAYANA HRUDAYALAYA
 
P/E (TTM) x - 44.5 - View Chart
P/BV x 9.3 11.7 79.9% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 KRSNAA DIAGNOSTICS   NARAYANA HRUDAYALAYA
EQUITY SHARE DATA
    KRSNAA DIAGNOSTICS
Mar-21
NARAYANA HRUDAYALAYA
Mar-21
KRSNAA DIAGNOSTICS/
NARAYANA HRUDAYALAYA
5-Yr Chart
Click to enlarge
High RsNA524 0.0%   
Low RsNA239 0.0%   
Sales per share (Unadj.) Rs998.8126.4 790.4%  
Earnings per share (Unadj.) Rs284.5-0.4 -77,969.3%  
Cash flow per share (Unadj.) Rs342.18.6 3,970.7%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %NM0- 
Book value per share (Unadj.) Rs355.554.6 650.6%  
Shares outstanding (eoy) m6.50204.36 3.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x03.0 0.0%   
Avg P/E ratio x0-1,045.3 0.0%  
P/CF ratio (eoy) x044.3 0.0%  
Price / Book Value ratio x07.0 0.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m077,948 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2966,272 4.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,49225,823 25.1%  
Other income Rs m122282 43.4%   
Total revenues Rs m6,61526,105 25.3%   
Gross profit Rs m3,4661,885 183.9%  
Depreciation Rs m3741,835 20.4%   
Interest Rs m259823 31.5%   
Profit before tax Rs m2,955-492 -600.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,105-418 -264.6%   
Profit after tax Rs m1,849-75 -2,479.9%  
Gross profit margin %53.47.3 731.4%  
Effective tax rate %37.484.9 44.1%   
Net profit margin %28.5-0.3 -9,863.9%  
BALANCE SHEET DATA
Current assets Rs m2,4816,651 37.3%   
Current liabilities Rs m1,8387,032 26.1%   
Net working cap to sales %9.9-1.5 -671.4%  
Current ratio x1.40.9 142.7%  
Inventory Days Days2533 75.6%  
Debtors Days Days4139 103.5%  
Net fixed assets Rs m3,56421,031 16.9%   
Share capital Rs m2,4892,044 121.8%   
"Free" reserves Rs m-1789,122 -2.0%   
Net worth Rs m2,31011,165 20.7%   
Long term debt Rs m1,6805,041 33.3%   
Total assets Rs m6,04527,682 21.8%  
Interest coverage x12.40.4 3,080.7%   
Debt to equity ratio x0.70.5 161.0%  
Sales to assets ratio x1.10.9 115.1%   
Return on assets %34.92.7 1,289.3%  
Return on equity %80.0-0.7 -11,984.5%  
Return on capital %80.52.0 3,941.7%  
Exports to sales %00-   
Imports to sales %00.1 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA29 0.0%   
Fx inflow Rs m0560 0.0%   
Fx outflow Rs m084 0.0%   
Net fx Rs m0477 0.0%   
CASH FLOW
From Operations Rs m1,0263,091 33.2%  
From Investments Rs m-611-1,130 54.1%  
From Financial Activity Rs m308-1,984 -15.5%  
Net Cashflow Rs m723-23 -3,092.0%  

Share Holding

Indian Promoters % 27.4 63.9 42.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 34.6 29.8 116.2%  
FIIs % 4.4 10.8 41.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 36.2 200.9%  
Shareholders   75,065 43,807 171.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KRSNAA DIAGNOSTICS With:   FORTIS HEALTHCARE    INDRAPRASTHA MEDICAL    THYROCARE TECHNOLOGIES    DR. LAL PATHLABS    MAX HEALTHCARE INSTITUTE    



Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

NARAYANA HRUDAYALAYA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 19, 2021 | Updated on Oct 19, 2021

Here's an analysis of the annual report of NARAYANA HRUDAYALAYA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of NARAYANA HRUDAYALAYA. Also includes updates on the valuation of NARAYANA HRUDAYALAYA.

NARAYANA HRUDAYALAYA Announces Quarterly Results (1QFY22); Net Profit Up 165.4% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, NARAYANA HRUDAYALAYA has posted a net profit of Rs 777 m (up 165.4% YoY). Sales on the other hand came in at Rs 9 bn (up 118.5% YoY). Read on for a complete analysis of NARAYANA HRUDAYALAYA's quarterly results.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KRSNAA DIAGNOSTICS SHARE PRICE


Jan 21, 2022 (Close)

TRACK KRSNAA DIAGNOSTICS

  • Track your investment in KRSNAA DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KRSNAA DIAGNOSTICS

KRSNAA DIAGNOSTICS 8-QTR ANALYSIS

COMPARE KRSNAA DIAGNOSTICS WITH

MARKET STATS